Whitepaper: The Disruption of the Audit Process during COVID-19

By Jens Mattuschka; Sharon Schnieder |

Post-Pandemic: Why Remote Audits are Here to Stay

In response to the impact of COVID-19, organizations across all industries are re-thinking processes and establishing creative solutions. For biopharma companies, a core focus is on maintaining continuity of medical supply while minimizing the disruption to manufacturing and services.

In this whitepaper, you'll learn the following:

- The Pros and Cons of Remote Audits
- How to Plan a Remote Audit
- What to Consider During and After a Remote Audit

Remote Audits

Access the whitepaper now to better identify the challenges in the audit process during COVID-19 in relation to your organization.


About the Authors

Portrait of Jens Mattuschka

Jens Mattuschka

Regional Vice President, Nordics, Central and Eastern Europe
World Courier
View Bio

Sharon Schnieder

Regional Quality Manager EMEA
World Courier
View Bio